SDS Biotech K.K. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2013
2014
2016
2017
2018
2019
Sales/Revenue
13,034
15,740
17,076
12,492
12,929
11,585
Cost of Goods Sold (COGS) incl. D&A
8,297
10,144
475
7,987
8,303
7,537
Gross Income
4,737
5,597
16,602
4,504
4,625
4,048
SG&A Expense
3,608
4,032
-
3,241
3,215
3,064
EBIT
1,129
1,565
1,618
-
1,410
984
Unusual Expense
-
-
-
2,189
972
417
Non Operating Income/Expense
5
53
7
80
875
36
Interest Expense
158
268
414
38
32
32
Pretax Income
1,010
1,376
1,324
882
467
574
Income Tax
331
504
502
114
286
182
Consolidated Net Income
679
872
822
769
181
391
Net Income
643
814
957
769
181
391
Net Income After Extraordinaries
643
814
957
769
181
391
Net Income Available to Common
643
814
957
769
181
391
EPS (Basic)
82.22
103.92
122.16
98.16
23.08
49.97
Basic Shares Outstanding
8
8
8
8
8
8
EPS (Diluted)
82.16
103.92
122.16
98.16
23.08
49.97
Diluted Shares Outstanding
8
8
8
8
8
8
EBITDA
1,599
2,046
2,093
1,710
1,699
1,139
Other Operating Expense
-
-
475
-
-
-
Non-Operating Interest Income
1
8
1
1
2
1
Minority Interest Expense
37
58
135
-
-
-
Equity in Affiliates (Pretax)
33
19
125
-
-
-
About SDS Biotech
View Profile
